Class II
Ongoing
Dopamine HCl Inj., USP, 200 mg/5 mL (40 mg/mL), 5 mL Single-dose, 25 vials per tray, Rx only, Distributed by Hospira, Inc., Lake Forest, IL 60045 USA, Vial NDC 0409-5820-11, Carton NDC 0409-5820-01.
Why: Lack of Assurance of Sterility
- Company
- Pfizer
Manhattan, NY, United States - Reported
- Sep 23, 2026
- Recall started
- Sep 4, 2026
- Where sold
- US Nationwide.
- Amount
- N/A
- Full product description
- Dopamine HCl Inj., USP, 200 mg/5 mL (40 mg/mL), 5 mL Single-dose, 25 vials per tray, Rx only, Distributed by Hospira, Inc., Lake Forest, IL 60045 USA, Vial NDC 0409-5820-11, Carton NDC 0409-5820-01.
- Lots / codes affected
- Lot # NL5230, Exp Date:10/2027
Class I: could cause serious harm or death. Class II: could cause temporary or treatable problems. Class III: unlikely to cause harm.